Neutrophil CD64 as a marker of infection in patients treated with tocilizumab

Vol.19 No.6

Neutrophil CD64 as a marker of infection in patients treated with tocilizumab

Toshihiro Matsui¹ , Akiko Komiya¹ , Kota Shimada¹ , Hisanori Nakayama¹ , Shigeto Tohma¹

Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, 18-1 Sakuradai, Sagamihara, Kanagawa 228-8522, Japan

5 February 2009

4 August 2009

29 August 2009

PDF　(member's only)

Without Abstract

CD64 - Infection - Interleukin-6 - Rheumatoid arthritis - Tocilizumab